J&J CEO Joaquin Duato: It's our mission to become the number 1 company in oncology by 2030

CNBC’s Angelica Peebles and Johnson & Johnson chairman and CEO Joaquin Duato join 'Squawk Box' to discuss the company's cancer drug pipeline, impact of GLP-1 drugs on cancer growth, FDA leadership overhaul, global drug pricing, and more.